ArticleCardiovascular endocrinology & metabolism2025

BRIDGE-DS study: evaluating the effectiveness and safety of dapagliflozin/sitagliptin combination in type 2 diabetes mellitus patients with heart failure.

Kandanat Purushothaman Nair Suresh Kumar et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.